Implication of oxidative stress in size-dependent toxicity of silica nanoparticles in kidney cells

Toxicology

Volumn 299, Issue 2-3, 2012, Pages 112-124

  Passagne, Isabelle ^a   Morille, Marie ^b   Rousset, Marine ^a   Pujalté, Igor ^a   L'Azou, Béatrice ^a  

^a UNIVERSITÉ DE BORDEAUX   (France)

^b INSERM   (France)

Author keywords

Cytotoxicity; Kidney; Nanoparticles; Oxidative stress; Silica; SiO2

Indexed keywords

CATALASE; GLUTATHIONE TRANSFERASE; HYDROETHIDINE; MALONALDEHYDE; NANOPARTICLE; REACTIVE OXYGEN METABOLITE; SILICON DIOXIDE; THIOREDOXIN REDUCTASE;

ANIMAL CELL; ARTICLE; CELL VACUOLE; CONTROLLED STUDY; CYTOTOXICITY; CYTOTOXICITY TEST; DISPERSION; ENDOCYTOSIS; HUMAN; HUMAN CELL; INTERNALIZATION; KIDNEY CELL; KIDNEY PROXIMAL TUBULE; LIPID PEROXIDATION; NONHUMAN; OXIDATIVE STRESS; PARTICLE SIZE; PHYSICAL CHEMISTRY; PINOCYTOSIS; PRIORITY JOURNAL; SURFACE PROPERTY; TRANSMISSION ELECTRON MICROSCOPY;

ANIMALS; ANTIOXIDANTS; CELL LINE; CELL SURVIVAL; ENDOCYTOSIS; ETHIDIUM; FLOW CYTOMETRY; HUMANS; KIDNEY; MALONDIALDEHYDE; MICROSCOPY, ELECTRON, TRANSMISSION; NANOPARTICLES; OXIDATIVE STRESS; PARTICLE SIZE; REACTIVE OXYGEN SPECIES; SILICON DIOXIDE;

SUS;

EID: 84862902475     PISSN: 0300483X     EISSN: 18793185     Source Type: Journal    
DOI: 10.1016/j.tox.2012.05.010     Document Type: Article

References (63)

1. Akhtar M.J., Ahamed M., Kumar S., Siddiqui H., Patil G., Ashquin M., Ahmad I. Nanotoxicity of pure silica mediated through oxidant generation rather than glutathione depletion in human lung epithelial cells. Toxicology 2010, 276:95-102.
2. Antognelli C., Gambelunghe A., Del Buono C., Murgia N., Talesa V.N., Muzi G. Crystalline silica Min-U-Sil 5 induces oxidative stress in human bronchial epithelial cells BEAS-2B by reducing the efficiency of antiglycation and antioxidant enzymatic defenses. Chem. Biol. Interact. 2009, 182:13-21.
3. Arslan Z., Ates M., McDuffy W., Agachan M.S., Farah I.O., Yu W.W., Bednar A.J. Probing metabolic stability of CdSe nanoparticles: alkaline extraction of free cadmium from liver and kidney samples of rats exposed to CdSe nanoparticles. J. Hazard. Mater. 2011, 192:192-199.
4. Auffan M., Rose J., Bottero J.Y., Lowry G.V., Jolivet J.P., Wiesner M.R. Towards a definition of inorganic nanoparticles from an environmental, health and safety perspective. Nat. Nanotechnol. 2009, 4:634-641.
5. Auffan M., Rose J., Wiesner M.R., Bottero J.Y. Chemical stability of metallic nanoparticles: a parameter controlling their potential cellular toxicity in vitro. Environ. Pollut. 2009, 157:1127-1133.
6. Auger A., Samuel J., Poncelet O., Raccurt O. A comparative study of non-covalent encapsulation methods for organic dyes into silica nanoparticles. Nanoscale Res. Lett. 2011, 6:328.
7. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 1976, 72:248-254.
8. Castranova V. Signaling pathways controlling the production of inflammatory mediators in response to crystalline silica exposure: role of reactive oxygen/nitrogen species. Free Radic. Biol. Med. 2004, 37:916-925.
9. Chen J., Dong X., Zhao J., Tang G. In vivo acute toxicity of titanium dioxide nanoparticles to mice after intraperitoneal injection. J. Appl. Toxicol. 2009, 29:330-337.
10. Chen J.F., Ding H.M., Wang J.X., Shao L. Preparation and characterization of porous hollow silica nanoparticles for drug delivery application. Biomaterials 2004, 25:723-727.
11. Chen Z., Meng H., Xing G., Chen C., Zhao Y., Jia G., Wang T., Yuan H., Ye C., Zhao F., Chai Z., Zhu C., Fang X., Ma B., Wan L. Acute toxicological effects of copper nanoparticles in vivo. Toxicol. Lett. 2006, 163:109-120.
12. Cho M., Cho W.S., Choi M., Kim S.J., Han B.S., Kim S.H., Kim H.O., Sheen Y.Y., Jeong J. The impact of size on tissue distribution and elimination by single intravenous injection of silica nanoparticles. Toxicol. Lett. 2009, 189:177-183.
13. Cocco P. Multifactorial aetiology of lung cancer among silica-exposed workers. Ann. Acad. Med. Singapore 2001, 30:468-474.
14. Cocco P., Dosemeci M., Rice C. Lung cancer among silica-exposed workers: the quest for truth between chance and necessity. Med Lav 2007, 98:3-17.
15. dos Santos T., Varela J., Lynch I., Salvati A., Dawson K.A. Effects of transport inhibitors on the cellular uptake of carboxylated polystyrene nanoparticles in different cell lines. PLoS One 2011, 6:e24438.
16. Eom H.J., Choi J. Oxidative stress of silica nanoparticles in human bronchial epithelial cell, Beas-2B. Toxicol. In Vitro 2009, 23:1326-1332.
17. Fruijtier-Polloth C. The toxicological mode of action and the safety of synthetic amorphous silica-a nanostructured material. Toxicology 2012, 294:61-79.
18. Fuller J.E., Zugates G.T., Ferreira L.S., Ow H.S., Nguyen N.N., Wiesner U.B., Langer R.S. Intracellular delivery of core-shell fluorescent silica nanoparticles. Biomaterials 2008, 29:1526-1532.
19. Gong C., Tao G., Yang L., Liu J., He H., Zhuang Z. The role of reactive oxygen species in silicon dioxide nanoparticle-induced cytotoxicity and DNA damage in HaCaT cells. Mol. Biol. Rep. 2012, 39:4915-4925.
20. Gonzalez L., Thomassen L.C., Plas G., Rabolli V., Napierska D., Decordier I., Roelants M., Hoet P.H., Kirschhock C.E., Martens J.A., Lison D., Kirsch-Volders M. Exploring the aneugenic and clastogenic potential in the nanosize range: A549 human lung carcinoma cells and amorphous monodisperse silica nanoparticles as models. Nanotoxicology 2010, 4:382-395.
21. Gratton S.E., Napier M.E., Ropp P.A., Tian S., DeSimone J.M. Microfabricated particles for engineered drug therapies: elucidation into the mechanisms of cellular internalization of PRINT particles. Pharm. Res. 2008, 25:2845-2852.
22. Gunness P., Aleksa K., Kosuge K., Ito S., Koren G. Comparison of the novel HK-2 human renal proximal tubular cell line with the standard LLC-PK1 cell line in studying drug-induced nephrotoxicity. Can. J. Physiol. Pharmacol. 2010, 88:448-455.
23. Hansen S.F., Michelson E.S., Kamper A., Borling P., Stuer-Lauridsen F., Baun A. Categorization framework to aid exposure assessment of nanomaterials in consumer products. Ecotoxicology 2008, 17:438-447.
24. He X., Nie H., Wang K., Tan W., Wu X., Zhang P. In vivo study of biodistribution and urinary excretion of surface-modified silica nanoparticles. Anal. Chem. 2008, 80:9597-9603.
25. IARC IARC Working Group on the evaluation of carcinogenic risks to humans: silica, some silicates, coal dust and para-aramid fibrils. Lyon, 15-22 October 1996. IARC Monogr. Eval. Carcinog. Risks Hum. 1997, 68:1-475.
26. Johannes L., Lamaze C. Clathrin-dependent or not: is it still the question?. Traffic 2002, 3:443-451.
27. Kaksonen M., Toret C.P., Drubin D.G. Harnessing actin dynamics for clathrin-mediated endocytosis. Nat. Rev. Mol. Cell Biol. 2006, 7:404-414.
28. L'Azou B., Jorly J., On D., Sellier E., Moisan F., Fleury-Feith J., Cambar J., Brochard P., Ohayon-Courtes C. In vitro effects of nanoparticles on renal cells. Part. Fibre Toxicol. 2008, 5:22.
29. Lai J.C., Ananthakrishnan G., Jandhyam S., Dukhande V.V., Bhushan A., Gokhale M., Daniels C.K., Leung S.W. Treatment of human astrocytoma U87 cells with silicon dioxide nanoparticles lowers their survival and alters their expression of mitochondrial and cell signaling proteins. Int. J. Nanomed. 2010, 5:715-723.
30. Lajoie P., Nabi I.R. Regulation of raft-dependent endocytosis. J. Cell. Mol. Med. 2007, 11:644-653.
31. Lin W., Huang Y.W., Zhou X.D., Ma Y. In vitro toxicity of silica nanoparticles in human lung cancer cells. Toxicol. Appl. Pharmacol. 2006, 217:252-259.
32. Lison D., Thomassen L.C., Rabolli V., Gonzalez L., Napierska D., Seo J.W., Kirsch-Volders M., Hoet P., Kirschhock C.E., Martens J.A. Nominal and effective dosimetry of silica nanoparticles in cytotoxicity assays. Toxicol. Sci. 2008, 104:155-162.
33. Lu X., Qian J., Zhou H., Gan Q., Tang W., Lu J., Yuan Y., Liu C. In vitro cytotoxicity and induction of apoptosis by silica nanoparticles in human HepG2 hepatoma cells. Int. J. Nanomed. 2011, 6:1889-1901.
34. Macia E., Ehrlich M., Massol R., Boucrot E., Brunner C., Kirchhausen T. Dynasore, a cell-permeable inhibitor of dynamin. Dev. Cell 2006, 10:839-850.
35. Mamdouh Z., Giocondi M.C., Laprade R., Le Grimellec C. Temperature dependence of endocytosis in renal epithelial cells in culture. Biochim. Biophys. Acta 1996, 1282:171-173.
36. Marano F., Hussain S., Rodrigues-Lima F., Baeza-Squiban A., Boland S. Nanoparticles: molecular targets and cell signalling. Arch. Toxicol. 2010.
37. Moller P., Jacobsen N.R., Folkmann J.K., Danielsen P.H., Mikkelsen L., Hemmingsen J.G., Vesterdal L.K., Forchhammer L., Wallin H., Loft S. Role of oxidative damage in toxicity of particulates. Free Radic. Res. 2010, 44:1-46.
38. Muller D., Houpert P., Cambar J., Henge-Napoli M.H. Role of the sodium-dependent phosphate co-transporters and of the phosphate complexes of uranyl in the cytotoxicity of uranium in LLC-PK1 cells. Toxicol. Appl. Pharmacol. 2006, 214:166-177.
39. 2 nanoparticles in MRC5 cell line. Romanian Biotechnol. Lett. 2010, 15:5000-5007.
40. Nabeshi H., Yoshikawa T., Matsuyama K., Nakazato Y., Arimori A., Isobe M., Tochigi S., Kondoh S., Hirai T., Akase T., Yamashita T., Yamashita K., Yoshida T., Nagano K., Abe Y., Yoshioka Y., Kamada H., Imazawa T., Itoh N., Tsunoda S., Tsutsumi Y. Size-dependent cytotoxic effects of amorphous silica nanoparticles on Langerhans cells. Pharmazie 2010, 65:199-201.
41. Nabeshi H., Yoshikawa T., Matsuyama K., Nakazato Y., Tochigi S., Kondoh S., Hirai T., Akase T., Nagano K., Abe Y., Yoshioka Y., Kamada H., Itoh N., Tsunoda S., Tsutsumi Y. Amorphous nanosilica induce endocytosis-dependent ROS generation and DNA damage in human keratinocytes. Part. Fibre Toxicol. 2011, 8:1.
42. Napierska D., Thomassen L.C., Lison D., Martens J.A., Hoet P.H. The nanosilica hazard: another variable entity. Part. Fibre Toxicol. 2010, 7:39.
43. Nichols B. Caveosomes and endocytosis of lipid rafts. J. Cell Sci. 2003, 116:4707-4714.
44. Nishimori H., Kondoh M., Isoda K., Tsunoda S., Tsutsumi Y., Yagi K. Silica nanoparticles as hepatotoxicants. Eur. J. Pharm. Biopharm. 2009, 72:496-501.
45. Park Y.H., Kim J.N., Jeong S.H., Choi J.E., Lee S.H., Choi B.H., Lee J.P., Sohn K.H., Park K.L., Kim M.K., Son S.W. Assessment of dermal toxicity of nanosilica using cultured keratinocytes, a human skin equivalent model and an in vivo model. Toxicology 2010, 267:178-181.
46. 6-methylguanine DNA-methyltransferase expression. J. Pharmacol. Exp. Ther. 2003, 307:816-823.
47. Powers K.W., Brown S.C., Krishna V.B., Wasdo S.C., Moudgil B.M., Roberts S.M. Research strategies for safety evaluation of nanomaterials. Part VI. Characterization of nanoscale particles for toxicological evaluation. Toxicol. Sci. 2006, 90:296-303.
48. Pujalte I., Passagne I., Brouillaud B., Treguer M., Durand E., Ohayon-Courtes C., L'Azou B. Cytotoxicity and oxidative stress induced by different metallic nanoparticles on human kidney cells. Part. Fibre Toxicol. 2011, 8:10.
49. Rabolli V., Thomassen L.C., Princen C., Napierska D., Gonzalez L., Kirsch-Volders M., Hoet P.H., Huaux F., Kirschhock C.E., Martens J.A., Lison D. Influence of size, surface area and microporosity on the in vitro cytotoxic activity of amorphous silica nanoparticles in different cell types. Nanotoxicology 2010, 4:307-318.
50. Rabolli V., Thomassen L.C., Uwambayinema F., Martens J.A., Lison D. The cytotoxic activity of amorphous silica nanoparticles is mainly influenced by surface area and not by aggregation. Toxicol. Lett. 2011, 206:197-203.
51. Rejman J., Oberle V., Zuhorn I.S., Hoekstra D. Size-dependent internalization of particles via the pathways of clathrin- and caveolae-mediated endocytosis. Biochem. J. 2004, 377:159-169.
52. Roger E., Lagarce F., Garcion E., Benoit J.P. Lipid nanocarriers improve paclitaxel transport throughout human intestinal epithelial cells by using vesicle-mediated transcytosis. J. Control. Release 2009, 140:174-181.
53. Ryan M.J., Johnson G., Kirk J., Fuerstenberg S.M., Zager R.A., Torok-Storb B. HK-2: an immortalized proximal tubule epithelial cell line from normal adult human kidney. Kidney Int. 1994, 45:48-57.
54. 2 ultra-fine particles: the role of surface iron. Sci. China Ser. B: Chem. 2009, 52:1033-1041.
55. Steenland K., Rosenman K., Socie E., Valiante D. Silicosis and end-stage renal disease. Scand. J. Work. Environ. Health 2002, 28:439-442.
56. Ushio-Fukai M. Localizing NADPH oxidase-derived ROS. Sci. STKE 2006, 2006:re8.
57. Vercauteren D., Piest M., Al Soraj M., Jones A.T., Engbersen J.F., De Smedt S.C., Braeckmans K. Unraveling the cellular uptake of bioreducible poly(amido amine)-gene complexes in cells of the retinal pigment epithelium. J. Control. Release 2010, 148:e99-e100.
58. Wang F., Gao F., Lan M., Yuan H., Huang Y., Liu J. Oxidative stress contributes to silica nanoparticle-induced cytotoxicity in human embryonic kidney cells. Toxicol. In Vitro 2009, 23:808-815.
59. Wang F., Jiao C., Liu J., Yuan H., Lan M., Gao F. Oxidative mechanisms contribute to nanosize silican dioxide-induced developmental neurotoxicity in PC12 cells. Toxicol. In Vitro 2009, 23:808-815.
60. Wang J., Zhou G., Chen C., Yu H., Wang T., Ma Y., Jia G., Gao Y., Li B., Sun J., Li Y., Jiao F., Zhao Y., Chai Z. Acute toxicity and biodistribution of different sized titanium dioxide particles in mice after oral administration. Toxicol. Lett. 2007, 168:176-185.
61. Waters K.M., Masiello L.M., Zangar R.C., Tarasevich B.J., Karin N.J., Quesenberry R.D., Bandyopadhyay S., Teeguarden J.G., Pounds J.G., Thrall B.D. Macrophage responses to silica nanoparticles are highly conserved across particle sizes. Toxicol. Sci. 2009, 107:553-569.
62. 2 nanoparticles induce cytotoxicity and protein expression alteration in HaCaT cells. Part. Fibre Toxicol. 2010, 7:1.
63. 2 induces apoptosis via activation of p53 and Bax mediated by oxidative stress in human hepatic cell line. Toxicol. In Vitro 2010, 24:751-758.